(1-tert-Butoxycarbonyl-piperidin-3-yl)-acetic acid, 95.0%, 25g

(3-Fluoro-5-(piperazin-1-ylmethyl)phenyl)boronic acid hydrochloride, 98%, 500mg

tert-Butyl ((1S,3S)-1-((2S,4S)-4-isopropyl-5-oxotetrahydrofuran-2-yl)-3-(4-methoxy-3-(3-methoxypropoxy)benzyl)-4-methylpentyl)carbamate, 95%, 25g

1,3,5-Trimethyl-4-nitro-1H-pyrazole, 95.0%, 1g

Ethyl 5-amino-6-methylnicotinate, 95.0%, 25g

2-Ethyl-3,5-dimethylpyrazine (contains 2-Ethyl-3,6-dimethylpyrazine)>98.0%(GC)25g

N-Acetyl-2-(4-nitrophenyl)ethylamine>98.0%(GC)5g

1-((3,4-Dimethoxyphenethyl)amino)-3-(m-tolyloxy)propan-2-ol hydrochloride, 98.0%, 25g

5-Bromovaleric Acid>97.0%(GC)(T)25g

Vaso de precipitados ROTILABO® de forma alta, 450 ml, 1 Pieza

(1R,2S,3R,5R)-3-Amino-5-(hydroxymethyl)cyclopentane-1,2-diol hydrochloride, 95.0%, 1g

6-Cyanonicotinic acid, 97.0%, 5g

6-Bromo-2,4-dichloro-3-nitroquinoline, 100mg